2019
Association between Serum Matrix Metalloproteinase‐ (MMP‐) 3 Levels and Systemic Lupus Erythematosus: A Meta‐analysis
Lee J, Kronbichler A, Park J, Kim S, Han K, Kang H, Ha I, Cheong H, Kim K, Kim G, Kim D, Chae H, Lee C, Lee K, Shin J. Association between Serum Matrix Metalloproteinase‐ (MMP‐) 3 Levels and Systemic Lupus Erythematosus: A Meta‐analysis. Disease Markers 2019, 2019: 9796735. PMID: 31396295, PMCID: PMC6668546, DOI: 10.1155/2019/9796735.Peer-Reviewed Original ResearchConceptsSerum MMP-3 levelsMMP-3 levelsSystematic lupus erythematosusSystematic lupus erythematosus patientsMMP-3Meta-analysisLupus erythematosusSubgroup analysisMatrix metalloproteinasesSystemic lupus erythematosusDNA antibody titersCase-control studyRenal involvementSLE cohortPersistent proteinuriaDisease activityEMBASE searchHealthy controlsPubMed searchRheumatic diseasesPatientsAntibody titersMatrix metalloproteinase-SerumDisease markers
2012
Caspase‐activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens
Jog NR, Frisoni L, Shi Q, Monestier M, Hernandez S, Craft J, Prak ET, Caricchio R. Caspase‐activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens. Arthritis & Rheumatism 2012, 64: 1247-1256. PMID: 22127758, PMCID: PMC3292632, DOI: 10.1002/art.33448.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusAutoimmune responseMouse modelApoptotic cellsNuclear autoantigensDNA antibody titersLupus-prone miceAbsence of CADMaintenance of toleranceAutoreactive B cellsAnti-DNA antibodiesApoptotic modificationsLupus developmentGeneration of autoantigensAntinuclear antibodiesLupus erythematosusAntibody titersAutoimmune diseasesActive caspase-3Apoptotic bodiesB cellsMiceAutoantigensCAD deficiencyCaspase-3
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply